Sanjib Chowdhury, PhD, MS

Research Assistant Professor, Medicine

Sanjib Chowdhury
(617) 638-8223
650 Albany St Evans Biomed Research Ctr


Dr. Sanjib Chowdhury is a Research Assistant Professor for the BU School of Medicine in the Section of Gastroenterology. Dr. Chowdhury received his PhD in Cancer Research and MS in Clinical & Translational Research from the University of Nebraska Medical Center, where he was previously an Assistant Professor of Surgery. He also attended the University of Calcutta where he received an MS & BS in Human Physiology.


  • University of Nebraska Medical Center, PhD
  • University of Nebraska Medical Center, MS
  • University of Calcutta, MSc
  • University of Calcutta, BSc


  • Published on 1/10/2018

    Roy P, Chowdhury S, Roy HK. Exercise-induced myokines as emerging therapeutic agents in colorectal cancer prevention and treatment. Future Oncol. 2018 02; 14(4):309-312. PMID: 29318900.

    Read at: PubMed
  • Published on 1/3/2018

    Somenath Datta, Richard M. Sherva, Mart De La Cruz, Michelle T. Long, Priya Roy, Vadim Backman, Sanjib Chowdhury*, Hemant K. Roy* (*corresponding authors). Single Nucleotide Polymorphism Facilitated Downregulation of the Cohesin Stromal Antigen-1: Implications for Colorectal Cancer Racial Disparities. Neoplasia. 2018; (Accepted ).

  • Published on 11/1/2017

    Caroline M. Robb, Smit Kour, Jacob I. Contreras, Ekta Agarwal, Carter J Barger, Sandeep Rana, Yogesh Sonawane, Beth K. Neilsen, Margaret Taylor, Smitha Kizhake, Rhishikesh N. Thakare, Sanjib Chowdhury, Jing Wang, Jennifer D. Black, Michael A. Hollingsworth, Michael G. Brattain, Amarnath Natarajan. Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy. Oncotarget. 2017; (Accepted).

  • Published on 4/17/2017

    Bailey KL, Agarwal E, Chowdhury S, Luo J, Brattain MG, Black JD, Wang J. TGFß/Smad3 regulates proliferation and apoptosis through IRS-1 inhibition in colon cancer cells. PLoS One. 2017; 12(4):e0176096. PMID: 28414818.

    Read at: PubMed
  • Published on 4/1/2017

    Datta S, Chowdhury S, Roy HK. Metabolism, microbiome and colorectal cancer. Aging (Albany NY). 2017 Apr; 9(4):1086-1087. PMID: 28455972.

    Read at: PubMed
  • Published on 3/28/2017

    Cruz MD, Ledbetter S, Chowdhury S, Tiwari AK, Momi N, Wali RK, Bliss C, Huang C, Lichtenstein D, Bhattacharya S, Varma-Wilson A, Backman V, Roy HK. Metabolic reprogramming of the premalignant colonic mucosa is an early event in carcinogenesis. Oncotarget. 2017 Mar 28; 8(13):20543-20557. PMID: 28423551.

    Read at: PubMed
  • Published on 3/26/2017

    Are C, Meyer B, Stack A, Ahmad H, Smith L, Qian B, Song T, Chowdhury S. Global trends in the burden of liver cancer. J Surg Oncol. 2017 Apr; 115(5):591-602. PMID: 28345140.

    Read at: PubMed
  • Published on 2/13/2017

    Douaiher J, Ravipati A, Grams B, Chowdhury S, Alatise O, Are C. Colorectal cancer-global burden, trends, and geographical variations. J Surg Oncol. 2017 Apr; 115(5):619-630. PMID: 28194798.

    Read at: PubMed
  • Published on 1/30/2017

    Are C, Ahmad H, Ravipati A, Croo D, Clarey D, Smith L, Price RR, Butte JM, Gupta S, Chaturvedi A, Chowdhury S. Global epidemiological trends and variations in the burden of gallbladder cancer. J Surg Oncol. 2017 Apr; 115(5):580-590. PMID: 28138977.

    Read at: PubMed
  • Published on 1/9/2017

    Agarwal E, Robb CM, Smith LM, Brattain MG, Wang J, Black JD, Chowdhury S. Role of Akt2 in regulation of metastasis suppressor 1 expression and colorectal cancer metastasis. Oncogene. 2017 Jun 01; 36(22):3104-3118. PMID: 28068324.

    Read at: PubMed

View 17 more publications: View full profile at BUMC

View all profiles